Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
Use this GNLX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GNLX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GNLX SEC filings page. Lician reads the product cache first so this HTML stays unique to Genelux Corporation Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full GNLX income, balance, and cash tables.